L-arginine reverses the antinatriuretic effect of cyclosporin in renal transplant patients

BACKGROUND: Cyclosporin has been shown to facilitate renal vasoconstriction and to have an antinatriuretic effect. The existence of an interference of cyclosporin with the vasodilating properties of endothelium mediated by nitric oxide production could mediate these effects. On the other hand, the infusion of the nitric oxide precursor L-arginine has been shown to induce renal vasodilatation and to facilitate natriuresis in normal volunteers. We have investigated the renal effects of the administration of an infusion of L-arginine in renal transplant patients chronically treated with cyclosporin. To facilitate the analysis of the data the effects of the administration of a similar dose of cyclosporin on renal function during the infusion of a vehicle were also investigated during the administration of a vehicle of L-arginine. DESIGN: Ten male renal transplant patients, chronically treated with cyclosporin and with a stable renal function were studied during 2 consecutive days after the administration of the usual morning dose of cyclosporin. The first day they received an intravenous infusion of vehicle and the second the infusion of graded doses of L-arginine (50, 100, 150 mg/kg/h) during 3 consecutive h. RESULTS: The first day, after cyclosporin administration a significant fall (P < 0.01) was observed in natriuresis and kaliuresis in the absence of changes in renal plasma flow and glomerular filtration rate. After the administration of L-arginine significant (P < 0.01) increases of renal plasma flow, glomerular filtration rate, and natriuresis were seen. The increase in blood levels of cyclosporin after its administration did not differ between days 1 and 2. CONCLUSION: These results indicate that L-arginine facilitates renal vasodilatation and natriuresis in renal transplant patients. Furthermore, the observed increase in sodium excretion could indicate that L-arginine counteracts the antinatriuretic effect of cyclosporin.      

基础医学教师课堂教学质量评价

为了了解本科教师的教学质量和教学效果 ,教学专家和学生评价了 14 7位基础医学教师。结果显示 ,讲师以上职称教师的教学质量明显好于初级职称教师 (P<0 .0 5 ) ,高级职称教师教学的科学性、艺术性和思想性明显好于讲师和助教 (P<0 .0 5 )。文章还对教学中存在的问题和对策进行了讨论。     

低剂量甲基汞在小鼠体内分布及其对细胞周期进程的影响

连续９０天饮用含甲基汞浓度为１／１０００ＬＤ５０、１／１００ＬＤ５０、１／５０ＬＤ５０和１／１０ＬＤ５０的自来水的雄性昆明小鼠，各脏器中总汞含量均高于对照组（Ｐ＜０．０５～０．００５），并且随着染毒剂量增加，脏器中总汞含量也随之增高。同时采用ＦＡＣＳｃａｎ流式细胞仪和“ＣｅｌｌＦＩＴ”软件分析脾细胞周期进程，发现除１／１０００ＬＤ５０剂量组外，其余各剂量组从Ｇｏ／Ｇ１时相进入Ｓ时相的脾细胞百分数均明显高于对照组（Ｐ＜０．０５），与染毒剂量呈明显正相关。表明连续经口摄入低剂量甲基汞小鼠脾细胞周期进程加快，细胞ＤＮＡ复制增强。     

卡维地洛干预心衰对大鼠心肌细胞凋亡和肌浆网钙泵活性的影响

目的　从细胞内钙调节和细胞凋亡角度探讨卡维地洛治疗心力衰竭的机制。方法　采用结扎冠状动脉复制心力衰竭大鼠模型 ,对照观察非选择性 β 受体阻滞剂卡维地洛和α1 受体阻滞剂特拉唑嗪干预心衰对左室心肌细胞凋亡率和肌浆网钙泵 (SERCA2a)活性的影响。结果　与对照组 (C组 )相比 ,心衰组 (F组 )SERCA2a活性显著降低 (P <0 .0 1) ,心肌细胞凋亡率显著升高 (P <0 .0 1) ;特拉唑嗪组 (T组 )心肌细胞凋亡率、SERCA2a活性与F组无显著差异 (P >0 .0 5 ) ;卡维地洛剂量依赖地降低心肌细胞凋亡率 ,增高SERCA2a活性。SERCA2a活性与心肌细胞凋亡率显著负相关 (r =-0 .814 ,P <0 .0 0 1) ,与 +dp/dtmax、-dp/dtmax显著正相关 (r =0 .691、0 .64 5 ,P <0 .0 0 1)。结论　SERCA2a活性异常 ,可能参与心力衰竭心肌细胞凋亡的调节。增加SERCA2a活性 ,抑制心肌细胞凋亡 ,可能是卡维地洛治疗心力衰竭的重要机制。卡维地洛的上述效应与α1 受体阻滞作用无关。     

方剂学科发展思路与方法

方剂学科传统模式已发生重大变化，现代方剂学以计算机和实验为重要研究手段，熔理论方剂学、实验方剂学及临床方剂学于一炉。现代方剂学科模式的建立必将培育出新的知识增长点，丰富学科内涵，促进研究方向和专业课程的调整，提高学术水平和人才培养质量，实现新世纪方剂学科发展质的飞跃。     

非小细胞肺癌转移预测指标的研究

目的 :研究非小细胞肺癌 (NSCLC)淋巴结和远处转移的预测指标 ,并建立Logistic回归模型。　 方法 :通过免疫组化、ELISA、酶谱电泳等方法 ,对NSCLC肿瘤病理标本、血清、尿液和骨髓等进行检查 ,并通过Logistic回归分析建立预测概率模型。　结果 :免疫组化指标肿瘤组织内微血管密度 (IMVD)、血管内皮细胞生长因子(VEGF)、碱性成纤维细胞生长因子 (b FGF)、白细胞分化抗原变异型 (CD4 4v6 )、基质金属蛋白酶 2 (MMP 2 )与NSCLC淋巴结转移危险有关 (P <0 .0 5 ) ,组织金属蛋白酶抑制物 (TIMP 2 )、上皮型钙粘素 (E cad)与NSCLC淋巴结转移危险下降有关 (P <0 .0 5 )。血清MMP 2、MMP 9,尿液MMP 2、MMP 9及骨髓上皮膜抗原 (EMA)阳性细胞与NSCLC远处转移危险有关 (P <0 .0 5 )。其中免疫组化指标CD4 4v6、IMVD、E cad及尿液MMP 2、骨髓EMA阳性细胞对NSCLC转移有显著回归效果而分别被选入概率模型 1和 2 ,其预测准确率分别为 81.1%和 72 .7%。　结论 :组织标本中CD4 4v6、IMVD、E cad以及尿液中MMP 2及骨髓EMA阳性细胞检查 ,可预测绝大多数NSCLC的淋巴结转移和远处转移状况 ,为NSCLC转移的早期诊断提供重要信息 ,有助于NSCLC的个体化治疗和改善预后     

口腔粘膜癌前病变及鳞癌角蛋白表达的免疫组化研究

目的 研究口腔粘膜标本中角蛋白的表达与分布。方法 利用多克隆抗角蛋白抗体Ａ５７５，采用免疫组化技术。结果 从正常口腔粘膜，轻、中、重度异常增生到鳞癌角蛋白表达显著增强，Ａ５７５在所有鳞癌标本中均为阳性，但染色强度深浅不一，且随鳞癌分化程度降低而降低，染色弱的病例其临床分期高，更易发生淋巴结转移。结论角蛋白表达的增强在强人上皮细胞中的致癌基因上起作用，这种强化的积累将加速癌前疾病的进展，因此，Ａ５７     

Acute management of intracranial hemorrhage in patients receiving thrombolytic therapy: case reports

Intracranial hemorrhage is an uncommon complication of antithrombotic therapy. We present two patients who suffered life-threatening intracranial bleeding as a complication of thrombolytic/anticoagulant treatment. Early diagnosis and treatment appear to be crucial factors for survival. We suggest an approach to perioperative management for intracranial hemorrhage resulting from antithrombotic therapy.     

Four cases of lung cancer associated with idiopathic interstitial pneumonia

It is well known that lung cancer develops frequently in patients with idiopathic interstitial pneumonia (IIP) (9.8-22.8%). We investigated 4 patients who developed lung cancer among the 28 patients with IIP (14.3%) who were admitted to our hospital from June 1981 to March 1989. Many reports have pointed out the clinical features of lung cancer associated with IIP as male sex, old age, heavy smoking, and poor prognosis. Our 4 series were agreed with these clinical features. Lung cancer associated with IIP have been often reported to occur in the lower and peripheral regions of the lung, and honeycomb structures are frequently seen. But we found that lung cancer in IIP could actually occur in both the lower and upper regions of the lung and does not occur only in the honeycomb structures. There was no obvious dominance of any histological type among the tumors. If lung cancer is suspected in a patient with IIP, tumor markers are of some value for diagnosis, but are not sensitive enough to be used alone.